Fujitsu
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
Also, Lupin has launched a new digital diabetes support programme.
It seeks to support and accelerate the development of personalised healthcare and drug discovery.
The trial aims to enable hospitals and nursing homes to quickly respond to emergency situations while ensuring patients' privacy.
They plan to release their digital solutions for insurance companies next year.
They aim to bring down the period and costs for new drug development.
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.